|
VAMP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.883140E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.660700E-03 |
| Normal-vs-Stage2 |
3.619600E-02 |
| Normal-vs-Stage3 |
1.052800E-01 |
| Normal-vs-Stage4 |
8.406200E-04 |
| Stage1-vs-Stage2 |
7.586400E-01 |
| Stage1-vs-Stage3 |
9.120600E-01 |
| Stage1-vs-Stage4 |
2.392600E-01 |
| Stage2-vs-Stage3 |
7.439600E-01 |
| Stage2-vs-Stage4 |
3.510600E-01 |
| Stage3-vs-Stage4 |
2.852400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.215600E-03 |
| Normal-vs-AfricanAmerican |
2.764300E-03 |
| Normal-vs-Asian |
2.753800E-02 |
| Caucasian-vs-AfricanAmerican |
5.926200E-01 |
| Caucasian-vs-Asian |
5.692400E-01 |
| AfricanAmerican-vs-Asian |
6.696600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.020470E-04 |
| Normal-vs-Female |
6.851600E-01 |
| Male-vs-Female |
1.318130E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.632400E-02 |
| Normal-vs-Extreme_Weight |
2.394300E-04 |
| Normal-vs-Obese |
8.018400E-03 |
| Normal-vs-Extreme_Obese |
3.010100E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.168400E-01 |
| Normal_Weight-vs-Obese |
8.735200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.313600E-01 |
| Extreme_Weight-vs-Obese |
5.447800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.028200E-01 |
| Obese-vs-Extreme_Obese |
3.085800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.308100E-02 |
| Normal-vs-Age(41-60Yrs) |
5.942300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.378370E-03 |
| Normal-vs-Age(81-100Yrs) |
1.506160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.959200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.339400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.498400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.526200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.288200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.842200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.441900E-04 |
| Normal-VS-Type2 PRCC |
1.988230E-02 |
| Normal-VS-KIRP CIMP |
7.251800E-01 |
| Normal-VS-Unclassified PRCC |
2.686200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.839200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.547200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.290200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.725600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.779200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.721800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.476800E-03 |
| Normal-vs-N1 |
2.351700E-02 |
| Normal-vs-N2 |
3.817200E-01 |
| N0-vs-N1 |
8.358200E-01 |
| N0-vs-N2 |
7.771000E-01 |
| N1-vs-N2 |
8.761200E-01 |
|
|
